Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
+7.35M
-
Total reported value, excl. options
-
$3.01B
-
Value change
-
+$631M
-
Put/Call ratio
-
2.03
-
Number of buys
-
114
-
Number of sells
-
-13
-
Price
-
$81.64
Significant Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q4 2020
164 filings reported holding BEAM - Beam Therapeutics Inc. - COMMON STOCK as of Q4 2020.
Beam Therapeutics Inc. - COMMON STOCK (BEAM) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
of 101M outstanding shares and own 36.46% of the company stock.
Largest 10 shareholders include FMR LLC (7.33M shares), Redmile Group, LLC (3.78M shares), Temasek Holdings (Private) Ltd (3.35M shares), BlackRock Inc. (3.16M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (2.97M shares), VANGUARD GROUP INC (2.82M shares), STATE STREET CORP (1.43M shares), ARK Investment Management LLC (1.13M shares), SC CHINA HOLDING Ltd (1.13M shares), and Cormorant Asset Management, LP (924K shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.